Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Lignocaine with dexmedetomidine: To determine time for intubation using 2 mcg/kg dexmedetomidine with lignocaine 2% nebulization for patients undergoing awake fiberoptic intubation foll
Sponsors
Department of Anaesthesiology
Eligibility
Inclusion criteria
Inclusion criteria: Patients that have given written, informed consent to participate the study, American Society of Anaesthesiologist physical status 1 , patients undergoing surgery under general anaesthesia
Exclusion criteria
Exclusion criteria: Refusal to participate study, Allergy to local anaesthetics or any of the study drugs, pregnant and lactation, contraindication to regional nerve block like bleeding disorder and infection at the site of block, emergency operation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intubation time after adding dexmedetomidine with lignocaine nebulization as additive to airway block during awake fiberoptic intubationTimepoint: At the time from passing the fiberoptic endoscope tip through the nostril to the first reading obtained by the capnograph after endotracheal intubation | — |
Secondary
| Measure | Time frame |
|---|---|
| Cough severity score, Intubating condition, Patient comfort score, Hemodynamic changes and Complications if anyTimepoint: 16 months | — |
Countries
India
Contacts
Public ContactDr Arpita Laha
IPGMER and SSKM Hospital
Outcome results
None listed